- Report
- December 2024
- 150 Pages
Global
From €3296EUR$3,750USD£2,851GBP
- Report
- April 2025
- 188 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- March 2025
- 180 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- March 2025
- 180 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- May 2025
- 135 Pages
Global
From €2636EUR$2,999USD£2,280GBP
- Report
- March 2025
- 144 Pages
Global
From €2636EUR$2,999USD£2,280GBP
- Report
- January 2025
- 125 Pages
Global
From €2636EUR$2,999USD£2,280GBP
- Report
- September 2025
- 285 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 290 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 363 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 284 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 281 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 274 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 177 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 182 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 190 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 370 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 381 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 263 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 474 Pages
Global
From €5142EUR$5,850USD£4,448GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more